Report cards › Food › Dr. Pepper/Seven Up, Inc.

CRUSH

Owned by Dr. Pepper/Seven Up, Inc. · 49 products in USDA FoodData Central · as of Oct 28, 2026 · Report an error · Change log

CSWH grade C (57)

Method v1.0 (how we grade), based on the records below; exact score 56.5918.

Grade by indicator
IndicatorGradeWhat we found
Recalls (40%)B (80)1 Class II (4 points) · 1 event For current recalls see FDA and USDA.
Ingredients (40%)F (11)Tier A: 8 of 49 products (Brominated vegetable oil (BVO)) · F (18) (25%)
Tier B: 47 of 49 products (FD&C Red No. 40, FD&C Blue No. 1, FD&C Yellow No. 6, FD&C Yellow No. 5) · F (0) (15%) · products
FDA warning letters (20%)A (100)None found to the owner Oct 28, 2021 to Oct 28, 2026.

Shown, not graded: recall reasons (1 foreign material) · IARC notes (0 products) · FDA dye pledge: none on FDA's tracker.

Recalls, Oct 28, 2021 to Oct 28, 2026

  1. Class II, Oct 27, 2023 · Foreign material · FDA event 93334

    • Crush Orange Soda, 24 Pack. 24 - 12 oz. cans. Caffeine Free. Contains No Juice. UPC 0 78000-01309 2. Produced under the Authority of Dr Pepper/Seven Up, Inc., 6425 Hall of Fame Lane, Frisco, TX 75034

      Reason (FDA's words)
      foreign material - plastic
      Code information
      JUL2924XXXXMC10243, Best by Date July 29th 2024
      Recalling firm
      Pepsi Beverages, LLC
      Dates
      Recall started Oct 27, 2023; classified Nov 2, 2023
      Status
      Terminated (status reported by FDA at classification)
      How we matched it
      matched by UPC 78000013092 (upc)

      FDA record F-0314-2024: openFDA · Report an error

Store-brand and co-packer recalls count on a brand only when a UPC in the recall matches one of its products.

Ingredients on our watch list

Products (47)

Labels change: each row shows the date of its FoodData Central record. A brand that has changed a recipe can report it with "Report an error".

FDA warning letters to Dr. Pepper/Seven Up, Inc., Oct 28, 2021 to Oct 28, 2026

None found from FDA food offices.

FDA notes that later events may have changed the regulatory status of what a letter discusses.